chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: I have had tachycardia events much more frequently and up to 1-2x/week; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 34 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 19Feb2021 13:00 (Lot number: EL8982) at the age of 34 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6200, Location of injection: Arm Right, Vaccine Administration Time: 09:00 AM, Route of Administration: Intramuscular), administration date: 29Jan2021, when the patient was 34 years old, for COVID-19 immunization. The following information was reported: TACHYCARDIA (non-serious) with onset 20Feb2021 12:00, outcome "recovered with sequelae" (2021), described as "I have had tachycardia events much more frequently and up to 1-2x/week". Therapeutic measures were not taken as a result of tachycardia.  Additional information- The patient had no other significant health changes, no medications, no major lifestyle changes, no changes in caffeine consumption. The only variable  had this year was the two doses of the vaccine, and obviously it could be coincidental, but the patient scared to get a booster. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no list of any other medications the patient received within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Body and joint pain; Temperature: 100.4; Chills; swollen lymph nodes; swollen injection site; Headache; Nausea; Fatigue; Body and joint pain; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTUERER UNKNOWN (where X=1, 2, or number unknown)), for COVID-19 Immunization. The following information was reported: PAIN (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "Body and joint pain"; PYREXIA (non-serious), outcome "unknown", described as "Temperature: 100.4"; CHILLS (non-serious), outcome "unknown", described as "Chills"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph nodes"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swollen injection site"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received Covid-19 booster shot. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Pain, Pyrexia, Vaccination site swelling
Clinical narrative: Body and joint pain; Temperature: 100.4; Chills; swollen lymph nodes; swollen injection site; Headache; Nausea; Fatigue; Body and joint pain; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTUERER UNKNOWN (where X=1, 2, or number unknown)), for COVID-19 Immunization. The following information was reported: PAIN (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "Body and joint pain"; PYREXIA (non-serious), outcome "unknown", described as "Temperature: 100.4"; CHILLS (non-serious), outcome "unknown", described as "Chills"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph nodes"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swollen injection site"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient received Covid-19 booster shot. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymphadenopathy, Oropharyngeal pain, Vaccination site pain
Clinical narrative: Enlarged supraclavicular lymph node; Headache; Sore throat; Pain at injection site; Joint pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 16:00 (Lot number: FF2589) at the age of 31 years as dose  2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer (Dose Number: 1, Batch/Lot No: FC3182, Location of injection: Arm Left, Vaccine Administration Time: 04:45 PM), administration date: 22Aug2021, for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Enlarged supraclavicular lymph node"; HEADACHE (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Headache"; OROPHARYNGEAL PAIN (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Sore throat"; VACCINATION SITE PAIN (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Pain at injection site"; ARTHRALGIA (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Joint pain". The events "enlarged supraclavicular lymph node", "headache", "sore throat", "pain at injection site" and "joint pain" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy, headache, oropharyngeal pain, vaccination site pain, arthralgia.  Additional information- patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: This is a spontaneous report received from noncontactable consumer or other non-HCP (patient). A 17-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FD0809), at the age of 17, in right arm, on Oct 4, 2021, at 14:45, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. The patient developed pyrexia (fever of 100.6 and climbing), onset Oct 5, 2021, at 13:00, with outcome of not recovered. Relevant laboratory tests and procedures available in the appropriate section. Additional information: Patient did not receive any other vaccine within four weeks of vaccination. Patient did not have COVID-19 prior vaccination and has not tested positive post vaccination. Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: fever; tired the next day; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): NVSC2021US072736_NS.  A 64 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "fever"; FATIGUE (non-serious), outcome "recovered", described as "tired the next day".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Swelling, Vaccination site erythema
Clinical narrative: Persistent redness right deltoid area (area of injection) more than 72 hours after injection; Redness tracks to right axilla; swelling and fullness in right axilla; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 02Oct2021 14:15 (Lot number: 301358) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NAPROXEN. Vaccination history included: Bnt162b2 (Prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL9269, prev dose lot unknown: False,, prev dose administrator route: intramuscular, prev dose administration date: 05Feb2021, prev dose dose number:2, prev dose vaccine location:Right, arm.), administration date: 05Feb2021, when the patient was 59 years old, for Covid-19 immunization; Bnt162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL3248, prev dose lot unknown: False,, prev dose administrator route: Intramusular, prev dose administration date: 15Jan2021, prev dose dose number 1, prev dose vaccine location: Right arm.), administration date: 15Jan2021, when the patient was 59 years old, for Covid-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "Persistent redness right deltoid area (area of injection) more than 72 hours after injection"; ERYTHEMA (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "Redness tracks to right axilla"; SWELLING (non-serious) with onset 03Oct2021 02:30, outcome "not recovered", described as "swelling and fullness in right axilla". Therapeutic measures were not taken as a result of vaccination site erythema, erythema, swelling.  Additional information: No known allergies, Post vaccination patient was not tested for COVID. Prior to vaccination patient had no COVID. Patient had no other medical history. Facility type Vaccine: Pharmacy or Drug Store. If other vaccine in four weeks: No  No follow-up attempts are possible. No further information is expected.  Follow-Up (13Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Discomfort
Clinical narrative: Chest Pressure where my heart is, right in the middle.; Discomfort all the time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Sep2021 14:00 (Lot number: 2589) at the age of 48 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PROGESTERONE; ESTROGEN; MULTIVITAMIN [VITAMINS NOS]. Past drug history included: Sulfa, reaction(s): "Allergy". The following information was reported: CHEST DISCOMFORT (non-serious) with onset 25Sep2021 04:00, outcome "not recovered", described as "Chest Pressure where my heart is, right in the middle."; DISCOMFORT (non-serious) with onset 25Sep2021 04:00, outcome "not recovered", described as "Discomfort all the time". Therapeutic measures were not taken as a result of chest discomfort, discomfort.  Additional information: Chest Pressure where heart is, right in the middle. Feels like patient have 30 pounds sitting on chest. Discomfort all the time. Started 4 days after shot and patient still have the issue 10 days later. Patient healthy and never had heart issue before. Patient had most recent Covid-19 vaccine in Pharmacy or Drug Store facility. Patient did not received any other vaccine within 4 weeks of Covid-19 vaccine. Patient was not diagnosed with Covid-19 prior to vaccination. Patient was not tested for Covid-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Headache, Myalgia
Clinical narrative: vomiting 3'sx; Abdominal pain; Horrible headache; chills; Joint pain; muscle aches; nausea; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 17:30 (Lot number: FC3183) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: BYSTOLIC. Vaccination history included: Bnt162b2 (Date of 1st dose - 24Aug2021, Time of 1st dose - Approx 5pm, Anatomical location - left arm, Batch/lot no: Pfizer Biotech FC3183), administration date: 24Aug2021, when the patient was 66 years old, for covid 19 immunization, reaction(s): "diarrhea", "abdominal pain", "nausea", "vomiting", "horrible headache", "chills", "joint pain", "muscle pain". The following information was reported: VOMITING (non-serious), outcome "unknown", described as "vomiting 3'sx"; ABDOMINAL PAIN (non-serious), outcome "not recovered", described as "Abdominal pain"; HEADACHE (non-serious), outcome "unknown", described as "Horrible headache"; CHILLS (non-serious), outcome "not recovered", described as "chills"; ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain"; MYALGIA (non-serious), outcome "unknown", described as "muscle aches"; NAUSEA (non-serious), outcome "not recovered", described as "nausea".  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: vomiting 3'sx; Abdominal pain; Horrible headache; chills; Joint pain; muscle aches; nausea; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 17:30 (Lot number: FC3183) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: BYSTOLIC. Vaccination history included: Bnt162b2 (Date of 1st dose - 24Aug2021, Time of 1st dose - Approx 5pm, Anatomical location - left arm, Batch/lot no: Pfizer Biotech FC3183), administration date: 24Aug2021, when the patient was 66 years old, for covid 19 immunization, reaction(s): "diarrhea", "abdominal pain", "nausea", "vomiting", "horrible headache", "chills", "joint pain", "muscle pain". The following information was reported: VOMITING (non-serious), outcome "unknown", described as "vomiting 3'sx"; ABDOMINAL PAIN (non-serious), outcome "not recovered", described as "Abdominal pain"; HEADACHE (non-serious), outcome "unknown", described as "Horrible headache"; CHILLS (non-serious), outcome "not recovered", described as "chills"; ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain"; MYALGIA (non-serious), outcome "unknown", described as "muscle aches"; NAUSEA (non-serious), outcome "not recovered", described as "nausea".  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have rashes just formed today underneath the armpit and next the groin area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 24 year-old male patient received bnt162b2 (BNT162B2), administration date 29Sep2021 (Lot number: FF2587) at the age of 24 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing), notes: Verbatim: Anxiety; "Depression" (unspecified if ongoing), notes: Verbatim: Depression. The patient's concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 04Oct2021, outcome "unknown", described as "I have rashes just formed today underneath the armpit and next the groin area".  Follow-Up (12Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: Nonstop menstrual Bleeding; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 02Sep2021 (Lot number: FC3180) at the age of 23 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HEAVY MENSTRUAL BLEEDING (non-serious) with onset 02Sep2021, outcome "not recovered", described as "Nonstop menstrual Bleeding". The event "nonstop menstrual bleeding" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of heavy menstrual bleeding.  Additional information: Patient did not receive any other vaccine in four weeks and no other medications in two weeks. Patient did not had covid prior and post vaccination. Patient did not have any known allergies. Patient had no known allergies.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dyspnoea, Headache, Myalgia
Clinical narrative: chills; Fever; muscle aches; chest pressure; shortness of breath; headache; running nose; sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Oct2021 (Batch/Lot number: unknown) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "asthma" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "angina" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; METOPROLOL; HUMULINE; GLIPIZIDE; ISOSORBIDA [ISOSORBIDE]. Past drug history included: Celexa, reaction(s): "Allergy"; Tramadol hcl, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 14Jan2021, for covid-19 immunisation; Bnt162b2 (Dose Number: 2, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 04Feb2021, for covid-19 immunisation. The following information was reported: CHILLS (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "Fever"; MYALGIA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "muscle aches"; CHEST DISCOMFORT (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "chest pressure"; DYSPNOEA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "shortness of breath"; HEADACHE (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "headache"; RHINORRHOEA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "running nose"; PAIN IN EXTREMITY (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "sore arm". Therapeutic measures were not taken as a result of chills, pyrexia, myalgia, chest discomfort, dyspnoea, headache, rhinorrhoea, pain in extremity.  Additional information Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rhinorrhoea
Clinical narrative: chills; Fever; muscle aches; chest pressure; shortness of breath; headache; running nose; sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Oct2021 (Batch/Lot number: unknown) at the age of 51 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "asthma" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "angina" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; METOPROLOL; HUMULINE; GLIPIZIDE; ISOSORBIDA [ISOSORBIDE]. Past drug history included: Celexa, reaction(s): "Allergy"; Tramadol hcl, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 14Jan2021, for covid-19 immunisation; Bnt162b2 (Dose Number: 2, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 04Feb2021, for covid-19 immunisation. The following information was reported: CHILLS (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "Fever"; MYALGIA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "muscle aches"; CHEST DISCOMFORT (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "chest pressure"; DYSPNOEA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "shortness of breath"; HEADACHE (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "headache"; RHINORRHOEA (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "running nose"; PAIN IN EXTREMITY (non-serious) with onset 04Oct2021 23:00, outcome "recovering", described as "sore arm". Therapeutic measures were not taken as a result of chills, pyrexia, myalgia, chest discomfort, dyspnoea, headache, rhinorrhoea, pain in extremity.  Additional information Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Headache, Hypoacusis, Muscle spasms
Clinical narrative: a headache that was so bad, I thought I was going to pass out; Joint pain; Muscle pain; Ringing in my ears; I can hardly hear, like my head is in a bucket; Ringing in my ears; I can hardly hear, like my head is in a bucket; feels like ants are and bugs are crawling all over my face all the time; Back pain; muscle spasms in my legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Sep2021 (Lot number: FF2588) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Verbatim: Blood pressure high; "Gout" (unspecified if ongoing), notes: Verbatim: Gout. Concomitant medication(s) included: METOPROLOL taken for hypertension (ongoing); OMEPRAZOLE taken for gastric ulcer (ongoing); ALLOPURINOL taken for gout (ongoing); PHENTERMINE taken for weight decreased (ongoing). The following information was reported: TINNITUS (non-serious), HYPOACUSIS (non-serious) all with onset 22Sep2021, outcome "unknown" and all described as "Ringing in my ears; I can hardly hear, like my head is in a bucket"; PARAESTHESIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "feels like ants are and bugs are crawling all over my face all the time"; BACK PAIN (non-serious) with onset 22Sep2021, outcome "unknown", described as "Back pain"; MUSCLE SPASMS (non-serious) with onset 22Sep2021, outcome "unknown", described as "muscle spasms in my legs"; HEADACHE (non-serious), outcome "unknown", described as "a headache that was so bad, I thought I was going to pass out"; ARTHRALGIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "Joint pain"; MYALGIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "Muscle pain".  Additional information: The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient stated that I have very serious ringing in my ears, I can hardly hear, like my head is in a bucket. I have tingling on the left side of my things, feels like ants are and bugs are crawling all over my face all the time, seriously bad joint pain, back pain, muscle pain and muscle spasms in my legs. Patient states "One is phentermine and the other one is metoprolol the dose of the metoprolol is 50mg for high blood pressure, once a day. Phentermine is 35mg for weight loss, twice a day. This is Omeprazole 40mg, once a day for stomach ulcer prevention. Allopurinol 300mg and that is for Gout once a day." Patient had taken Tylenol 650mg, two tablets, twice a day.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Paraesthesia, Tinnitus
Clinical narrative: a headache that was so bad, I thought I was going to pass out; Joint pain; Muscle pain; Ringing in my ears; I can hardly hear, like my head is in a bucket; Ringing in my ears; I can hardly hear, like my head is in a bucket; feels like ants are and bugs are crawling all over my face all the time; Back pain; muscle spasms in my legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Sep2021 (Lot number: FF2588) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Verbatim: Blood pressure high; "Gout" (unspecified if ongoing), notes: Verbatim: Gout. Concomitant medication(s) included: METOPROLOL taken for hypertension (ongoing); OMEPRAZOLE taken for gastric ulcer (ongoing); ALLOPURINOL taken for gout (ongoing); PHENTERMINE taken for weight decreased (ongoing). The following information was reported: TINNITUS (non-serious), HYPOACUSIS (non-serious) all with onset 22Sep2021, outcome "unknown" and all described as "Ringing in my ears; I can hardly hear, like my head is in a bucket"; PARAESTHESIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "feels like ants are and bugs are crawling all over my face all the time"; BACK PAIN (non-serious) with onset 22Sep2021, outcome "unknown", described as "Back pain"; MUSCLE SPASMS (non-serious) with onset 22Sep2021, outcome "unknown", described as "muscle spasms in my legs"; HEADACHE (non-serious), outcome "unknown", described as "a headache that was so bad, I thought I was going to pass out"; ARTHRALGIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "Joint pain"; MYALGIA (non-serious) with onset 22Sep2021, outcome "unknown", described as "Muscle pain".  Additional information: The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient stated that I have very serious ringing in my ears, I can hardly hear, like my head is in a bucket. I have tingling on the left side of my things, feels like ants are and bugs are crawling all over my face all the time, seriously bad joint pain, back pain, muscle pain and muscle spasms in my legs. Patient states "One is phentermine and the other one is metoprolol the dose of the metoprolol is 50mg for high blood pressure, once a day. Phentermine is 35mg for weight loss, twice a day. This is Omeprazole 40mg, once a day for stomach ulcer prevention. Allopurinol 300mg and that is for Gout once a day." Patient had taken Tylenol 650mg, two tablets, twice a day.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Pyrexia
Clinical narrative: I had chills; my temperature is 100.7/ fever; Joint pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 04Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "I had chills"; PYREXIA (non-serious), outcome "unknown", described as "my temperature is 100.7/ fever"; ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain". Relevant laboratory tests and procedures are available in the appropriate section.  Comment: Reporter type could not be probed hence captured by default as Consumer or other non-health professional in tab.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: Arm Pain; This is a spontaneous report received from a contactable reporter (Consumer).  A 54 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 17Mar2021 10:30 (Lot number: EP6955) at the age of 54 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Covid-19", start date: Apr2020 (unspecified if ongoing), notes: in Apr2020. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 17Mar2021, outcome "recovered" (2021), described as "Arm Pain". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller stated the patient had Covid back in last Apr2020. Stated with the first vaccine, other than a little bit of arm pain she was fine. Patient has received both first and second doses of the Pfizer Covid Vaccine. First vaccine dose received on 17Mar2021, LOT: EP6955 and Second vaccine received on 06Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain, Pyrexia
Clinical narrative: put me out for the next day with all over body aches; headache; fever; muscle soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Mar2021 18:00 (Lot number: ER8727) at the age of 57 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "bipolar disorder (type I)" (unspecified if ongoing); "obesity" (unspecified if ongoing). Concomitant medication(s) included: CLONAZEPAM; OXCARBAZEPINE; LOVASTATIN; LEVOTHYROXINE. Past drug history included: Codeine, reaction(s): "allergies", notes: allergies: Codeine and Ultracet are meds that affect me badly; Ultracet, reaction(s): "allergies", notes: allergies: Codeine and Ultracet are meds that affect me badly. Vaccination history included: Bnt162b2 (dose number=1, lot number=EN6208, administration time=02:00 PM, vaccine location=Left arm, Minimal effects first dose), administration date: 09Mar2021, when the patient was 57 years old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 31Mar2021, outcome "unknown", described as "put me out for the next day with all over body aches"; HEADACHE (non-serious) with onset 31Mar2021, outcome "unknown", described as "headache"; PYREXIA (non-serious) with onset 31Mar2021, outcome "unknown", described as "fever"; MYALGIA (non-serious) with onset 31Mar2021, outcome "unknown", described as "muscle soreness".   Additional information: The patient had no covid prior vaccination. The patient had not tested to covid post vaccination.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Chest pain, Chills, Myalgia, Pain
Clinical narrative: Body Aches; Chest Pain; Chills; Asthma Attack; Muscle Pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 04Oct2021 (Lot number: ff2589) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "Covid" (unspecified if ongoing). Concomitant medication(s) included: BREO ELLIPTA; LEXAPRO. The following information was reported: PAIN (non-serious) with onset 04Oct2021 19:00, outcome "not recovered", described as "Body Aches"; CHEST PAIN (non-serious) with onset 04Oct2021 19:00, outcome "not recovered", described as "Chest Pain"; CHILLS (non-serious) with onset 04Oct2021 19:00, outcome "not recovered", described as "Chills"; ASTHMA (non-serious) with onset 04Oct2021 19:00, outcome "not recovered", described as "Asthma Attack"; MYALGIA (non-serious) with onset 04Oct2021 19:00, outcome "not recovered", described as "Muscle Pain". Therapeutic measures were not taken as a result of pain, chest pain, chills, asthma, myalgia.  Additional Information: if other vaccine in four weeks: No, if covid prior vaccination: yes, other medications in two weeks: breo inhaler, Lexapro, if covid tested post vaccination: No. patient had known allergies: No  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis, SARS-CoV-2 test
Clinical narrative: I had bronchitis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BRONCHITIS (non-serious), outcome "unknown", described as "I had bronchitis". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that, patient went home today (at the time of reporting) and found out his wife was positive. She had both Pfizer shots he had both Pfizer shots, A week and a half ago he was negative for covid 19. What the hell we gonna do now. He had bronchitis. Now what do he do. Should he go back to the clinic tomorrow to get retested? Do he need extra medications? They got some stuff that takes the crap out of his lungs waiting for that to come in. He can't believe this. He told her to not to get stressed about it. Sick of the bologna. He still wear my mask, stuff on his hands.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Blood test, Magnetic resonance imaging, Nerve stimulation test, Pruritus
Clinical narrative: She reports her daughter's itching started about 1.5 to 2 hours after receiving the first Covid 19 vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 47 year-old female patient received bnt162b2 (BNT162B2), administration date 18Feb2021 17:15 (Batch/Lot number: unknown) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: JUNEL FE taken for oral contraception. The following information was reported: PRURITUS (non-serious) with onset 18Feb2021, outcome "recovered" (2021), described as "She reports her daughter's itching started about 1.5 to 2 hours after receiving the first Covid 19 vaccine". The event "she reports her daughter's itching started about 1.5 to 2 hours after receiving the first covid 19 vaccine" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pruritus.  Additional information: Reporter daughter takes birth control pills, Junel FE, but there was no interaction. Therapeutic measures were taken as a result of pruritus included Benadryl. Reporter thinks vaccine administered on the right arm because that was the arm that her daughter moves the most. Additional Vaccines administered on Same Date of the Pfizer Suspect was none. Prior Vaccinations (within 4 weeks) and list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine was none. AE(s) following prior vaccinations was none. Reporter seriousness for the event itching was Unspecified. Patient received the second Covid 19 vaccine on 11Mar2021.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101317746 similar report from same reporter
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Myalgia, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Excessive nasal drainage resulting in sore throat; Excessive nasal drainage resulting in soar throat; This creates an intermittent cough; These symptoms are in addition to muscle aches and headaches.; These symptoms are in addition to muscle aches and headaches.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 15:45 (Lot number: 301458A) at the age of 69 years as dose 3, single for covid-19 immunisation. Relevant medical history included: "Diabetes (Type2)" (unspecified if ongoing), notes: Other medical history: Diabetes (Type2), High blood pressure; "High blood pressure" (unspecified if ongoing), notes: Other medical history: Diabetes (Type2), High blood pressure. Concomitant medication(s) included: METFORMIN; AMLODIPINE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9266, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, Administration date: 19Feb2021), administration date: 19Feb2021, when the patient was 69 years old, for Covid-19 Immunization; Pfizer (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, Administration date: 29Jan2021), administration date: 29Jan2021, when the patient was 69 years old. The following information was reported: RHINORRHOEA (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "Excessive nasal drainage resulting in sore throat"; OROPHARYNGEAL PAIN (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "Excessive nasal drainage resulting in soar throat"; COUGH (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "This creates an intermittent cough"; MYALGIA (non-serious), HEADACHE (non-serious) all with onset 03Oct2021 15:00, outcome "not recovered" and all described as "These symptoms are in addition to muscle aches and headaches.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rhinorrhoea, oropharyngeal pain, cough, myalgia, headache. Additional information : Patient did not receive any other vacancies four week prior to vaccination. Patient receive treatment for AE. (Ibuprofen and OTC flu type medication). patient not covid positive prior to vaccination, Post vaccination on 05Oct2021 patient undergo Nasal Swab test and result is negative.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Excessive nasal drainage resulting in sore throat; Excessive nasal drainage resulting in soar throat; This creates an intermittent cough; These symptoms are in addition to muscle aches and headaches.; These symptoms are in addition to muscle aches and headaches.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 15:45 (Lot number: 301458A) at the age of 69 years as dose 3, single for covid-19 immunisation. Relevant medical history included: "Diabetes (Type2)" (unspecified if ongoing), notes: Other medical history: Diabetes (Type2), High blood pressure; "High blood pressure" (unspecified if ongoing), notes: Other medical history: Diabetes (Type2), High blood pressure. Concomitant medication(s) included: METFORMIN; AMLODIPINE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9266, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, Administration date: 19Feb2021), administration date: 19Feb2021, when the patient was 69 years old, for Covid-19 Immunization; Pfizer (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, Administration date: 29Jan2021), administration date: 29Jan2021, when the patient was 69 years old. The following information was reported: RHINORRHOEA (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "Excessive nasal drainage resulting in sore throat"; OROPHARYNGEAL PAIN (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "Excessive nasal drainage resulting in soar throat"; COUGH (non-serious) with onset 03Oct2021 15:00, outcome "not recovered", described as "This creates an intermittent cough"; MYALGIA (non-serious), HEADACHE (non-serious) all with onset 03Oct2021 15:00, outcome "not recovered" and all described as "These symptoms are in addition to muscle aches and headaches.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rhinorrhoea, oropharyngeal pain, cough, myalgia, headache. Additional information : Patient did not receive any other vacancies four week prior to vaccination. Patient receive treatment for AE. (Ibuprofen and OTC flu type medication). patient not covid positive prior to vaccination, Post vaccination on 05Oct2021 patient undergo Nasal Swab test and result is negative.  No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Oropharyngeal pain, Pyrexia, Urticaria
Clinical narrative: started having hives all over his body; fever; chills; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 20 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Oct2021 (Lot number: 30155BA) at the age of 20 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Pfizer COVID First dose:  10Sep2021, LOT: FD08CG, states she doesn't understand the writing, because the letters are all together, Expiry Date: Unknown, Unknown, Injection, left arm, unknown dosage, injection), administration date: 10Sep2021, when the patient was 20 years old, for COVID-19 Immunization. The following information was reported: URTICARIA (non-serious) with onset 04Oct2021, outcome "unknown", described as "started having hives all over his body"; PYREXIA (non-serious) with onset 02Oct2021, outcome "recovered" (02Oct2021), described as "fever"; CHILLS (non-serious) with onset 02Oct2021, outcome "recovered" (02Oct2021), described as "chills"; OROPHARYNGEAL PAIN (non-serious) with onset 02Oct2021, outcome "recovered", described as "sore throat".  Additional information: The patient was taking Pfizer COVID 19 Vaccine, they all decided because they had a 7 year old at home and he works so hopefully it helps. It was reported that she gave her age but its to report a side effect of the second dose of the Pfizer BioNTech COVID vaccine, for her son. He got the, well they all got the second dose of the vaccine on Friday, but he got fever, chills, sore throat and then by monday, he started having hives all over his body. Fever; chills; sore throat: Confirms began about 6 hours after getting the shot. He got it about 5:30 in the afternoon and started feeling that way over night, so confirms began 02Oct2021 and was just a one day thing and confirms recovered completely 02Oct2021. She confirmed the product the patient received was the Pfizer COVID 19 Vaccine.  No follow-up attempts are possible. No further information is expected.